ChartMeds E-MAR System Review - why 3.6 stars?

ChartMeds E-MAR System Review
ITQlick Score: 73/100
ITQlick Rating:
Pricing: 4/10 - average cost
Category: Long-Term Care -> ChartMeds review
Ranking:Ranked 41 out of 51 Long-Term Care systems
Company: ChartMeds
Pricing: starts at $6.80 per month
Typical customers: Small, medium and large size businesses
Platforms: Mobile, Cloud
Links: ChartMeds E-MAR System pricing, ChartMeds E-MAR System alternatives
Shlomi LaviShlomi Lavi / updated: Apr 11, 2022

We publish unbiased reviews. Our opinions are our own and are not influenced by payments from advertisers. This content is reader-supported, which means if you leave your details with us we may earn a commission. Learn why ITQlick is free .

What is ChartMeds E-MAR System?

The most common problems were confusion, oversedation, hallucinations, or bleeding due to prescribing errors or failure to carefully monitor patients for side effects. The researchers found that some blood thinners, and antipsychotic drugs caused the most problems.

Average Rating

The rating of ChartMeds E-MAR System is 3.6 stars out of 5 and the total score is 73 out of 100. The rating score is based on our unbiased data-based algo. Learn more - rating methodology page.

Typical Customers

The typical customers include the following business size: Small, medium and large size businesses


List of categories

Billing & Invoicing
Assisted Living
Staff Permissions
Long-Term Care

List of features

Billing & Invoicing
Employee Scheduling

Auditor - Shlomi Lavi

Website Linkedin profile Facebook Twitter

Shlomi Lavi is an entrepreneur and founder of ITQlick.com. He holds a Bachelor of Science (B.Sc.) in Information Systems Engineering from Ben Gurion University in Israel. Shlomi brings 17 years of global IT and IS management experience as a consultant and implementation expert for small, medium and large-sized (global) companies. Shlomi’s goal is to share the best knowledge and news about information systems so you can make smarter buying decisions for your business.